Eupraxia Pharmaceuticals EPRX Balance Sheet (2022-2026)

NASDAQ EPRX
$8.06 +0.43 (+5.64%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

Eupraxia Pharmaceuticals Quarterly Balance Sheet

Periods 13 quarters
Latest Sep 2026

Eupraxia Pharmaceuticals reported total assets of $134.56M and total liabilities of $13.52M for the quarter ended Sep 2026, up 45.7% year over year. This balance sheet covers 13 quarters of results from Dec 2022 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet Dec2022 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv. 18.26M19.34M35.91M23.32M8.66M33.10M27.45M19.77M88.96M80.56M58.50M52.43M75.18M
Short-term InvestmentsInvestments (Current) 80.38M81.23M51.25M
Cash & Current Investments 18.26M19.34M35.91M23.32M8.66M33.10M27.45M19.77M88.96M80.56M138.88M133.66M126.42M
Receivables - NetNet Receivables 0.09M0.15M0.17M0.16M0.11M0.26M0.24M0.13M0.14M0.72M0.66M0.69M0.20M
Receivables - OtherOther Receivables 0.09M0.19M0.23M0.67M
Receivables 0.18M0.34M0.17M0.16M0.11M0.49M0.24M0.13M0.14M1.39M0.66M0.69M0.20M
Prepaid Assets 0.24M0.27M0.14M0.00M1.11M0.91M2.93M2.30M3.86M2.58M2.46M3.33M
Current Assets 18.59M19.80M36.22M24.53M9.89M34.44M28.61M22.83M91.40M85.10M142.13M136.80M129.95M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net) 0.44M0.41M0.38M0.35M0.37M0.36M0.50M0.66M0.68M0.83M1.16M1.21M1.22M
Other Non-Current Assets 0.00M0.01M0.01M1.05M1.12M0.08M0.08M0.08M0.10M0.06M0.06M0.05M0.05M
Non-Current Assets 0.53M0.46M0.42M0.45M0.47M0.51M0.63M0.77M0.95M1.05M3.23M3.10M4.61M
Assets 19.12M20.27M36.64M24.98M10.36M34.94M29.23M23.60M92.35M86.15M145.35M139.91M134.56M
Liabilities
Current Liabilities
Accounts Payables 2.93M3.92M3.97M1.98M2.29M3.03M2.15M2.58M3.73M5.55M7.16M8.39M10.10M
Payables 2.93M3.92M3.97M1.98M2.29M3.03M2.15M2.58M3.73M5.55M7.16M8.39M10.10M
Short term Debt 0.08M10.40M-0.36M
Current Leases 0.05M0.05M0.07M0.05M0.04M0.08M0.08M0.20M0.16M0.51M
Current Taxes 8.74M
Total Current Liabilities 3.06M19.37M11.60M2.37M3.10M3.81M5.63M7.36M8.55M10.61M
Non-Current Liabilities
Non-Current Debt 0.14M0.06M0.04M0.02M
Convertible Debt 8.74M10.34M9.48M4.53M
Minority Interest -0.58M-1.32M-1.44M-1.49M-1.54M-1.57M-1.57M-1.58M-1.59M-1.60M-1.60M-1.60M
Operating Leases 0.05M0.05M0.04M0.07M0.08M0.09M0.08M1.80M1.68M2.91M
Total Liabilities 11.91M19.37M18.53M11.64M2.39M1.54M2.20M2.62M3.91M4.11M9.17M10.23M13.52M
Shareholder's Equity
Total Debt 0.22M10.46M0.04M0.02M-0.36M
Common Equity 7.21M0.89M18.11M13.34M7.98M33.40M27.03M20.98M88.44M82.04M136.19M129.67M121.05M
Liabilities and Shareholders Equity 19.12M20.27M36.64M24.98M10.36M34.94M29.23M23.60M92.35M86.15M145.35M139.91M134.56M
Retained Earnings -77.28M-105.50M-111.54M-117.55M-123.49M-131.00M-146.51M-152.87M-169.58M-182.23M-196.72M-211.96M
Preferred Shares 31.71M29.74M

Eupraxia Pharmaceuticals Balance Sheet API

Pull Eupraxia Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=EPRX&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY